As potent antioxidants, omega-3 PUFAs upregulate Nrf2, mitogen-activated protein kinase (MAPK) phosphatases, GSH and HO-1 genes
While clinical development for obesity was discontinued in 2007 after a Phase IIb trial failed to achieve its primary endpoint, the peptide remains a valuable research tool for investigating adipose tissue biology, lipolytic pathways, and receptor-independent signaling mechanisms
Further, biomarker concentrations are tricky to interpret: Total GSH concentration often fails to accurately reflect redox balance, which is better indicated by the GSH to GSSG ratio, plasma/serum concentrations are often a weak correlate of tissue level (the locus of action), and compartmentalization within cells (cytosol versus mitochondria) adds another layer of complexity often out of grasp in clinical samples [31]
Safety Advice of Omega-3 Fatty Acid 500 Mg + Lutein 5 Mg + Vitamin C 150 Mg + Zinc Sulphate 12.5 Mg + Elemental Copper 1 Mg + Glutathione 5 Mg + Vitamin E 200 Iu + Zeaxanthin 1 Mg Capsule Pregnancy: Use only if recommended by a healthcare provider
The Drugs Controller General of India (DCGI) has approved several GLP-1 drugs for treating type 2 diabetes and weight loss